European Stocks Muted as Novartis Shares Fall Most on Record

Novartis AG shares fell on Tuesday following a clinical-trial setback, the company's third such failure within a week. European stock indexes remained relatively flat on the day. The pharmaceutical company's decline affected broader market performance.

Next story